Objectives: We aimed to evaluate the incidence and patterns of late gadolinium
enhancement (LGE) in different forms of left ventricular hypertrophy (LVH) and to determine …

Objectives: This study sought to assess the rate of progression of fibrosis by 2 consecutive
cardiac magnetic resonance (CMR) examinations and its relation with clinical variables …

Background—Fibrosis is a common end point of many pathological processes affecting the
myocardium and may alter myocardial relaxation properties. By measuring myocardial …

Background The presence of myocardial fibrosis is associated with worse clinical outcomes
in hypertrophic cardiomyopathy (HCM). Cardiovascular magnetic resonance (CMR) with late …

The relationship among myocardial fibrosis, segmental strains, and hypertrophic
cardiomyopathy (HCM) in patients with preserved left ventricular ejection fraction is not …

Fibrotic remodelling of the extracellular matrix is a healing mechanism necessary
immediately after myocardial injury. However, prolonged increase in myocardial fibrotic …

Aims Myocardial fibrosis as detected by late gadolinium enhancement (LGE) on cardiac
magnetic resonance (CMR) is a powerful prognostic marker in hypertrophic cardiomyopathy …

Objectives: The objective of this study was to perform a systematic review and meta-analysis
of the predictive value of late gadolinium enhancement (LGE) cardiac magnetic resonance …

Background Cardiac magnetic resonance (CMR) T1 mapping has been used to characterize
myocardial diffuse fibrosis. The aim of this study is to determine the reproducibility and …

Myocardial fibrosis, seen in ischemic and nonischemic cardiomyopathies, is associated with
adverse cardiac outcomes. Noninvasive imaging plays a key role in early identification and …